Thursday, April 25, 2024
4/25/2024
PROJECT SUMMARY Norepinephrine (NE) and epinephrine (Epi) have been implicated in complex cognitive functions, such as sensory processing, sleep-wake/arousal state transition and attention, in the brain, and other biological processes in various tissues and organs, including the heart, pancreas and spleen. Dysregulation of adrenergic transmission is linked to a number of neurological diseases, including Alzheimer’s disease, depressive disorders and schizophrenia, as well as many other health problems, including cardiovascular diseases, immune-deficiency and tumorigenesis. Despite the potential involvement of NE/Epi in myriad physiological and pathological conditions, the precise regulation and exact functional role of adrenergic transmission remain poorly defined, due primarily to limitations of available tools for monitoring NE/Epi. We have recently developed a family of intensity-based G-protein-coupled receptor (GPCR) activation-based genetically encoded NE (GRABNE) sensors by coupling a circular permutated green fluorescent protein (cpGFP) with a human adrenergic receptor. While these GRABNE sensors allowed the first visualization of adrenergic transmission, the sensors were suboptimal in determining synaptic properties of adrenergic transmission. To facilitate NE/Epi research, we recently engineered high-performance GRABNE sensors that allowed high-sensitivity and high-resolution visualization of adrenergic transmission events at single release sites. The new sensors and preliminary data build up our confidence to test the hypothesis that high-performance GRABNE sensors may resolve the adrenergic transmission properties that could deduce the adrenergic functional role. This application follows two specific aims: Aim 1 is to determine whether high-performance GRABNE sensors may resolve adrenergic transmission properties, and Aim 2 is to test whether adrenergic transmission plays an essential role in the precision- and attention-demanding behaviors. We expect the proposed experiments to characterize the first set of fundamental synaptic properties of a new form of neuronal transmission and define a novel, unique functional role for adrenergic transmission.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
